{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:48:52Z","timestamp":1770752932916,"version":"3.50.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ymgmr.2021.100709","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T18:54:22Z","timestamp":1611168862000},"page":"100709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Co-therapy with S-adenosylmethionine and nicotinamide riboside improves t-cell survival and function in Arts Syndrome (PRPS1 deficiency)"],"prefix":"10.1016","volume":"26","author":[{"given":"Nina","family":"Lenherr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Duley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"Dobritzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynette","family":"Fairbanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre N.","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Filges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"G\u00fcrtler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Roelofsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 B.P.","family":"van Kuilenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"Szinnai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2021.100709_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/127013","article-title":"Association of PRPS1 Mutations with Disease Phenotypes","author":"Mittal","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ymgmr.2021.100709_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.410330519","article-title":"X-linked ataxia, weakness, deafness, and loss of vision in early childhood with a fatal course","volume":"33","author":"Arts","year":"1993","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ymgmr.2021.100709_bb0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ajhg.2010.02.024","article-title":"PRPS1 mutations: four distinct syndromes and potential treatment","volume":"9;86","author":"de Brouwer","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2021.100709_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-9-24","article-title":"X-linked Charcot-Marie-Tooth disease, Arts syndrome, and prelingual non-syndromic deafness form a disease continuum: evidence from a family with a novel PRPS1 mutation","volume":"9","author":"Synofzik","year":"2014","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2021.100709_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/14992027.2012.736032","article-title":"Hearing loss and PRPS1 mutations: wide spectrum of phenotypes and potential therapy","volume":"52","author":"Liu","year":"2013","journal-title":"Int. J. Audiol."},{"key":"10.1016\/j.ymgmr.2021.100709_bb0030","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10545-014-9731-6","article-title":"Inborn errors of purine metabolism: clinical update and therapies","volume":"37","author":"Balasubramaniam","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgmr.2021.100709_bb0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/ars.2007.1672","article-title":"+\/NADH and NADP+\/NADPH in cellular functions and cell death: regulation and biological consequences","volume":"10","author":"Ying","year":"2008","journal-title":"Antioxid. Redox Signal."},{"issue":"2\u20133","key":"10.1016\/j.ymgmr.2021.100709_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0009-8981(88)90145-3","article-title":"Altered erythrocyte nucleotide patterns are characteristic of inherited disorders of purine or pyrimidine metabolism","volume":"171","author":"Simmonds","year":"1988","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.ymgmr.2021.100709_bb0045","first-page":"657","article-title":"Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection","volume":"16","author":"Chi","year":"2013","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100709_bb0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in vivo evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymgmr.2021.100709_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41514-017-0016-9","article-title":"Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study","volume":"3","author":"Dellinger","year":"2017","journal-title":"NPJ Aging Mech Dis"},{"key":"10.1016\/j.ymgmr.2021.100709_bb0060","doi-asserted-by":"crossref","unstructured":"Porrmann J, Betcheva-Krajcir E, Di Donato N, Kahlert AK, Schallner J, Rump A, Schr\u00f6ck E, Dobritzsch D, Roelofsen J, van Kuilenburg ABP, Tzschach A. Novel PRPS1gain-of-function mutation in a patient with congenital hyperuricemia and facial anomalies. Am. J. Med. Genet. A 2017 173(10):2736\u20132742.","DOI":"10.1002\/ajmg.a.38359"},{"key":"10.1016\/j.ymgmr.2021.100709_bb0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using Bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgmr.2021.100709_bb0070","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0006-2952(01)00756-0","article-title":"The cytostatic- and differentiation-inducing effects of cyclopentenyl cytosine on human neuroblastoma cell lines","volume":"62","author":"Bierau","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgmr.2021.100709_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/BJ20061066","article-title":"Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site","volume":"401","author":"Li","year":"2007","journal-title":"Biochem. J."},{"issue":"Pt 4","key":"10.1016\/j.ymgmr.2021.100709_bb0080","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"10.1016\/j.ymgmr.2021.100709_bb0085","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"},{"key":"10.1016\/j.ymgmr.2021.100709_bb0090","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fimmu.2018.00678","article-title":"The CD8 T cell response to respiratory virus infections","volume":"9","author":"Schmidt","year":"2018","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.ymgmr.2021.100709_bb0095","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1128\/JVI.01069-10","article-title":"Memory CD4 T cell direct protective responses to influenza virus in the lungs through helper-independent mechanisms","volume":"84","author":"Teijaro","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.ymgmr.2021.100709_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01697","article-title":"potential mechanisms connecting purine metabolism and Cancer therapy","volume":"9","author":"Yin","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ymgmr.2021.100709_bb0105","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.celrep.2017.10.029","article-title":"The mTORC1 signaling network senses changes in cellular purine nucleotide levels","volume":"21","author":"Hoxhaj","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymgmr.2021.100709_bb0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fimmu.2017.00247","article-title":"Nutrient and metabolic sensing in T cell responses","volume":"8","author":"Wei","year":"2017","journal-title":"Front. Immunol."},{"issue":"1 Supplement","key":"10.1016\/j.ymgmr.2021.100709_bb0115","article-title":"Immunosuppression reverse engineered from cancer: Reducing nicotinamide adenine dinucleotide (NAD) impairs effector T cell function through glycolysis","volume":"200","author":"Ulf","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymgmr.2021.100709_bb0120","series-title":"Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual","first-page":"397","article-title":"Analysis of purines and pyrimidines in blood, urine and other physiological fluids","author":"Simmonds","year":"1991"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:31Z","timestamp":1762001491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426921000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":24,"alternative-id":["S2214426921000033"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100709","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-therapy with S-adenosylmethionine and nicotinamide riboside improves t-cell survival and function in Arts Syndrome (PRPS1 deficiency)","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100709"}}